We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00221533
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : December 28, 2007
Sponsor:
Information provided by:

Study Description
Brief Summary:
Relation between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients

Condition or disease
Vascular Diseases Arterial Stiffness

Study Design

Study Type : Observational
Estimated Enrollment : 250 participants
Time Perspective: Prospective
Official Title: Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients
Study Start Date : March 2004
Study Completion Date : August 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aged between 18 and 80 years, extremes included
  • Kidney transplants with or without other transplant organs
  • Informed consent
  • Stable clinical condition on the basis of a pre-trial physical examination, medical history, and the results of blood biochemistry and haematology tests

Exclusion Criteria:

  • Pregnant, lactating females
  • Recent (< 4 weeks) change in antihypertensive drug medication
  • Current or recent (< 2 weeks) acute illness such as infection or bleeding
  • Current treatment for malignancy
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00221533


Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Francis Verbeke, MD University Hospital, Ghent
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00221533     History of Changes
Other Study ID Numbers: 2005/196
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: December 28, 2007
Last Verified: December 2007

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases